Liye Zhou

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Ravindra Uppaluri, Katie M. Campbell, Ann Marie Egloff et al. · Clinical Cancer Research · 2020 · 365 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti–PD-1 Resistance in Head and Neck Cancer

Liye Zhou, Tenny Mudianto, Xiaojing Ma et al. · Clinical Cancer Research · 2019 · 260 citations · Full text

Medicine, Immunology, Oncology +16

Measuring the Caregiver Burden of Caring for Community-Residing People with Alzheimer’s Disease

Hongmei Yu, Xiaochen Wang, Runlian He et al. · PLoS ONE · 2015 · 151 citations · Full text

Medicine, Geriatric Medicine, Dementia +16

TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response

Zexian Zeng, Cheryl J. Wong, Lin Yang et al. · Nucleic Acids Research · 2021 · 132 citations · Full text

Life Sciences, Immunology, Oncology +17

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

Giacomo Oliveira, Ann Marie Egloff, Alexander B. Afeyan et al. · Science Immunology · 2023 · 116 citations · Full text

Medicine, Immunology, Oncology +17